This aspect of stage 3 type 1 diabetes (i.e. when to start insulin once hyperglycaemia is confirmed) requires further evidence to support clinical practice, to better understand the metabolic and mental-health outcomes. The gene discussed is INS; the disease is Hyperglycemia.